L’EFSA publie toutes ses productions scientifiques, y compris ses avis scientifiques, dans l’EFSA Journal. L’Autorité édite également un éventail de publications connexes à l’appui des productions scientifiques. Voir aussi : Definitions of EFSA Scientific Outputs and Supporting Publications.
To monitor antimicrobial resistance in zoonotic and indicator bacteria from food‐producing animal populations and meat thereof under Decision 2020/1729, a guidance for randomised sampling procedures is provided. Prospective and retrospective sampling plan ...
Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs), jointly analysed by EFSA and ECDC and reported in a yearly EU Summary Report. The annual monitori ...
In 2019, no lumpy skin disease (LSD) outbreaks were reported in South‐Eastern Europe, the mass vaccination regional campaign with homologous LSD vaccine continued for the fourth year with over 1.8 million bovines vaccinated in the region, preventing furth ...
The epidemics of lumpy skin disease in EU has been controlled mainly thanks to the coordinated control measures, taken in the Balkan region, based above all on regional vaccination campaign. Since before the epidemics EFSA has been performing risk assessm ...
In 2018, no lumpy skin disease (LSD) outbreaks were reported in the Balkan region, after the decline reported in 2017 (385) compared to 2016 (7,483). This confirms the effectiveness of the vaccination campaign based on the LSD homologous vaccine strain wh ...
The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resista ...
Abstract The epidemics of lumpy skin disease in EU has been controlled mainly thanks to the coordinated control measures taken in the Balkan region, based above all on regional vaccination campaign. Since before the epidemics EFSA has been performing risk ...
The duration of the vaccination campaign sufficient to eliminate lumpy skin disease (LSD) mainly depends on the vaccination effectiveness and coverage achieved. By using a spread epidemiological model, assuming a vaccination effectiveness of 65%, with 50% ...
The data on antimicrobial resistance in zoonotic and indicator bacteria in 2016, submitted by 28 EU Member States (MSs), were jointly analysed by the EFSA and ECDC. Resistance in bacterial isolates of zoonotic Salmonella and Campylobacter from humans, ani ...
The spatial and temporal patterns of lumpy skin disease (LSD) epidemics were analysed based on the data collected from affected and at-risk countries in southeastern Europe in 2016 and 2017. The reported outbreaks decreased from 7,483 in 2016 to 385 in ...
EFSA Journal on Wiley